Drug Profile
PT 1-2
Alternative Names: PT 1.2; PTS1.2/A; SASPject PT1.2; SASPject PTSA1.2/ALatest Information Update: 28 Apr 2018
Price :
$50
*
At a glance
- Originator Phico Therapeutics
- Class Antibacterials; DNA-binding proteins
- Mechanism of Action Bacterial DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Staphylococcal infections
Most Recent Events
- 28 Apr 2018 No recent reports of development identified for phase-I development in Staphylococcal-infections in United Kingdom (Intranasal, Gel)
- 13 Apr 2016 Phase I development is ongoing in United Kingdom
- 23 Jul 2013 Phase-I development is ongoing in United Kingdom